September is Prostate Health Month. MGH urologists discuss the prostate, its impact on men’s health and offer advice on PSA screenings.
Prostate Health Month
featuring video discussions with MGH urologists about general prostate health issues and prostate cancer
Over 200,000 men in the United States are diagnosed with prostate cancer each year. The American Cancer Society estimates that nearly 30,000 deaths occurring from prostate cancer in the U.S. will happen in 2012, making it the second leading cause of cancer death in men.
Aria Olumi, MD, staff urologist and director of Urology Research, shares his insight on what the general public needs to know about prostate cancer and PSA screenings. Olumi says while guidelines that hospitals have used to diagnose patients over the last two decades have led to an increase in men being diagnosed, there has also been an over diagnosis of prostate cancer and over treatment. His advice to patients is to discuss their screening and treatment options with their primary care physicians, cancer specialists or urologists.
While prostate cancer is an important health issue, there are other concerns related to the prostate. One of them, enlarged prostate, also known as benign hypertrophy (BPH), is a non-cancerous disorder affecting about 70 percent of men over the age of 50. BPH sometimes causes urinary problems such as incontinence and voiding dysfunction (irritated bladders, having to use the bathroom more often, more urgency, etc)
Shahin Tabatabaei, MD, staff urologist and director of the Prostate Health Program, talks in this video about the prostate’s location and function, the problems it presents, symptoms to look out for and modern treatments that help patients.
For more information about prostate health, visit the MGH Urology website.